Bristol-Myers all set to Buy Amylin for $5.3 Billion

Bristol-Myers all set to Buy Amylin for $5.3 Billion

By Jay Raol - Jul 02, 2012

Bristol-Myers Squibb Co (BMY) is planning to buy Amylin Pharmaceuticals Inc (AMLN), a biotechnology company, for nearly about 5.3 billion dollars cash price. This significant step

Read More